CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 100  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0555
LYS 10.0026
GLU 20.0044
LEU 30.0028
ARG 40.0050
CYS 50.0110
GLN 60.0157
CYS 70.0171
ILE 80.0411
LYS 90.0326
THR 100.0362
TYR 110.0308
SER 120.0293
LYS 130.0467
PRO 140.0337
PHE 150.0396
HIS 160.0324
PRO 170.0296
LYS 180.0426
PHE 190.0226
ILE 200.0069
LYS 210.0133
GLU 220.0086
LEU 230.0010
ARG 240.0094
VAL 250.0137
ILE 260.0083
GLU 270.0304
SER 280.0207
GLY 290.0242
PRO 300.0168
HIS 310.0086
CYS 320.0113
ALA 330.0316
ASN 340.0254
THR 350.0159
GLU 360.0066
ILE 370.0118
ILE 380.0113
VAL 390.0075
LYS 400.0074
LEU 410.0121
SER 420.0206
ASP 430.0270
GLY 440.0186
ARG 450.0233
GLU 460.0103
LEU 470.0206
CYS 480.0175
LEU 490.0069
ASP 500.0152
PRO 510.0099
LYS 520.0317
GLU 530.0247
ASN 540.0209
TRP 550.0087
VAL 560.0061
GLN 570.0165
ARG 580.0124
VAL 590.0169
VAL 600.0082
GLU 610.0077
LYS 620.0099
PHE 630.0078
LEU 640.0130
LYS 650.0187
ARG 660.0092
ALA 670.0555
GLU 680.0261
ASN 690.0367

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.